RESUMO
Cortical sensory maps are remodeled during early life to adapt to the surrounding environment. Both sensory and contextual signals are important for induction of this plasticity, but how these signals converge to sculpt developing thalamocortical circuits remains largely unknown. Here we show that layer 1 (L1) of primary auditory cortex (A1) is a key hub where neuromodulatory and topographically organized thalamic inputs meet to tune the cortical layers below. Inhibitory interneurons in L1 send narrowly descending projections to differentially modulate thalamic drive to pyramidal and parvalbumin-expressing (PV) cells in L4, creating brief windows of intracolumnar activation. Silencing of L1 (but not VIP-expressing) cells abolishes map plasticity during the tonotopic critical period. Developmental transitions in nicotinic acetylcholine receptor (nAChR) sensitivity in these cells caused by Lynx1 protein can be overridden to extend critical-period closure. Notably, thalamocortical maps in L1 are themselves stable, and serve as a scaffold for cortical plasticity throughout life.
Assuntos
Córtex Auditivo/fisiologia , Interneurônios/fisiologia , Plasticidade Neuronal/fisiologia , Filtro Sensorial/fisiologia , Animais , Córtex Auditivo/citologia , Bicuculina/farmacologia , Biguanidas/farmacologia , Potenciais Evocados Auditivos do Tronco Encefálico/efeitos dos fármacos , Potenciais Evocados Auditivos do Tronco Encefálico/genética , Potenciais Pós-Sinápticos Excitadores/efeitos dos fármacos , Potenciais Pós-Sinápticos Excitadores/genética , Feminino , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Plasticidade Neuronal/efeitos dos fármacos , Nicotina/farmacologia , Agonistas Nicotínicos/farmacologia , Emissões Otoacústicas Espontâneas/genética , Parvalbuminas/genética , Parvalbuminas/metabolismo , Filtro Sensorial/genética , Agonistas do Receptor de Serotonina/farmacologia , Peptídeo Intestinal Vasoativo/genética , Peptídeo Intestinal Vasoativo/metabolismoRESUMO
We previously reported a 84-Kb hemi-deletion copy number variant at the SLC1A1 gene locus that reduces its expression and appeared causally linked to schizophrenia. In this report, we characterize the in vivo and in vitro consequences of reduced expression of Slc1a1 in mice. Heterozygous (HET) Slc1a1+/- mice, which more closely model the hemi-deletion we found in human subjects, were examined in a series of behavioral, anatomical and biochemical assays. Knockout (KO) mice were also included in the behavioral studies for comparative purposes. Both HET and KO mice exhibited evidence of increased anxiety-like behavior, impaired working memory, decreased exploratory activity and impaired sensorimotor gating, but no changes in overall locomotor activity. The magnitude of changes was approximately equivalent in the HET and KO mice suggesting a dominant effect of the haploinsufficiency. Behavioral changes in the HET mice were accompanied by reduced thickness of the dorsomedial prefrontal cortex. Whole transcriptome RNA-Seq analysis detected expression changes of genes and pathways involved in cytokine signaling and synaptic functions in both brain and blood. Moreover, the brains of Slc1a1+/- mice displayed elevated levels of oxidized glutathione, a trend for increased oxidative DNA damage, and significantly increased levels of cytokines. This latter finding was further supported by SLC1A1 knockdown and overexpression studies in differentiated human neuroblastoma cells, which led to decreased or increased cytokine expression, respectively. Taken together, our results suggest that partial loss of the Slc1a1 gene in mice causes haploinsufficiency associated with behavioral, histological and biochemical changes that reflect an altered redox state and may promote the expression of behavioral features and inflammatory states consistent with those observed in schizophrenia.
Assuntos
Cognição , Transportador 3 de Aminoácido Excitatório/genética , Regulação da Expressão Gênica , Inflamação/genética , Esquizofrenia/genética , Psicologia do Esquizofrênico , Filtro Sensorial/genética , Animais , Ansiedade/genética , Apoptose , Comportamento Animal , Encéfalo/metabolismo , Encéfalo/patologia , Citocinas/metabolismo , Dano ao DNA , Modelos Animais de Doenças , Feminino , Redes Reguladoras de Genes , Genótipo , Glutationa/metabolismo , Haploinsuficiência/genética , Hipocampo/metabolismo , Hipocampo/patologia , Inflamação/imunologia , Inflamação/metabolismo , Locomoção/genética , Masculino , Camundongos , Camundongos Knockout , Oxirredução , Estresse Oxidativo , Córtex Pré-Frontal/metabolismo , Córtex Pré-Frontal/patologia , Esquizofrenia/imunologia , Esquizofrenia/metabolismo , Sinapses/metabolismoRESUMO
Developmental dyslexia is a common disorder with a strong genetic component, but the underlying molecular mechanisms are still unknown. Several candidate dyslexia-susceptibility genes, including KIAA0319, DYX1C1, and DCDC2, have been identified in humans. RNA interference experiments targeting these genes in rat embryos have shown impairments in neuronal migration, suggesting that defects in radial cortical migration could be involved in the disease mechanism of dyslexia. Here we present the first characterisation of a Kiaa0319 knockout mouse line. Animals lacking KIAA0319 protein do not show anatomical abnormalities in any of the layered structures of the brain. Neurogenesis and radial migration of cortical projection neurons are not altered, and the intrinsic electrophysiological properties of Kiaa0319-deficient neurons do not differ from those of wild-type neurons. Kiaa0319 overexpression in cortex delays radial migration, but does not affect final neuronal position. However, knockout animals show subtle differences suggesting possible alterations in anxiety-related behaviour and in sensorimotor gating. Our results do not reveal a migration disorder in the mouse model, adding to the body of evidence available for Dcdc2 and Dyx1c1 that, unlike in the rat in utero knockdown models, the dyslexia-susceptibility candidate mouse homolog genes do not play an evident role in neuronal migration. However, KIAA0319 protein expression seems to be restricted to the brain, not only in early developmental stages but also in adult mice, indicative of a role of this protein in brain function. The constitutive and conditional knockout lines reported here will be useful tools for further functional analyses of Kiaa0319.
Assuntos
Movimento Celular/genética , Dislexia/genética , Dislexia/patologia , Neocórtex/patologia , Proteínas do Tecido Nervoso/deficiência , Neurônios/fisiologia , Fatores Etários , Animais , Animais Recém-Nascidos , Ansiedade/etiologia , Ansiedade/genética , Encéfalo/metabolismo , Adaptação à Escuridão/genética , Modelos Animais de Doenças , Dislexia/complicações , Eletroporação , Embrião de Mamíferos , Feminino , Regulação da Expressão Gênica no Desenvolvimento/genética , Genótipo , Técnicas In Vitro , Antígeno Ki-67/metabolismo , Proteínas Luminescentes/genética , Proteínas Luminescentes/metabolismo , Masculino , Potenciais da Membrana/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Neocórtex/metabolismo , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Neurogênese/genética , Fator de Transcrição PAX6/metabolismo , Técnicas de Patch-Clamp , Gravidez , Inibição Pré-Pulso/genética , Interferência de RNA , Proteínas Repressoras/genética , Proteínas Repressoras/metabolismo , Filtro Sensorial/genética , Proteínas com Domínio T/metabolismo , Proteínas Supressoras de Tumor/genética , Proteínas Supressoras de Tumor/metabolismoRESUMO
Three electrophysiological endophenotypes are routinely studied in schizophrenia (SCZ): smooth pursuit eye movement (SPEM) dysfunction, deficits in P50 auditory-evoked potential inhibition, and saccadic inhibition deficits. The current study aimed to investigate the relationship between the COMT val158met polymorphism and these three endophenotypes. One hundred four SCZ patients (DSM-IV-R criteria) and 89 healthy controls were included in this study. P50 auditory-evoked potential inhibition, antisaccade paradigm and SPEM were analyzed. All individuals were genotyped for the COMT val158met. SCZ patients showed a higher rate of deficits measured by the SPEM, antisaccade and P50 inhibition paradigms without association with COMT val158met. However, in our control group, we have found an association between the Val polymorphism and the smoking status. More importantly, we have found a higher accuracy of saccades during the predictive pursuit task associated to the Met polymorphism in controls but not in SCZ patients who were receiving antidopaminergic medications. This result is in line with the hypothesis of the relationship between the Met polymorphism of the COMT gene, a higher level of dopamine in the prefrontal cortex and the role of the fronto-cerebellar loop in smooth predictive pursuit.
Assuntos
Catecol O-Metiltransferase/genética , Potenciais Evocados Auditivos/fisiologia , Movimentos Oculares/fisiologia , Inibição Psicológica , Esquizofrenia/genética , Esquizofrenia/fisiopatologia , Filtro Sensorial/fisiologia , Adulto , Endofenótipos , Movimentos Oculares/genética , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo Genético , Filtro Sensorial/genética , Adulto JovemRESUMO
Pregnancy is a period characterized by a supraphysiological hormonal status, and greater anxiety proneness, which can lead to peripartum affective symptoms with dramatic consequences not only for the woman but also for the child. Clinical psychiatry is heavily hampered by the paucity of objective and biology-based intermediate phenotypes. Prepulse inhibition (PPI) of the startle response, a neurophysiological measure of sensorimotor gating, has been poorly investigated in relation to anxiety and in pregnant women. In the present study, the PPI of healthy non-pregnant women (n = 82) and late pregnant women (n = 217) was investigated. Age, BMI, depression and anxiety symptoms, tobacco use, and antidepressant medication were considered. We investigated and provided evidence of lower PPI: (i) in healthy pregnant women compared to healthy non-pregnant controls, (ii) in pregnant women with anxiety disorders compared to healthy pregnant women, (iii) in pregnant women with anxiety disorders using SSRI compared to un-medicated pregnant women with anxiety disorders, and (iv) in healthy pregnant women carrying the COMT Val158Met Val/Val genotype compared to Met carriers. Altogether, a reduced sensorimotor gating as an effect of supraphysiological hormonal status, anxiety disorders, SSRIs, and catecholaminergic genotype, implicate the putative relevance of lower PPI as an objective biological correlate of anxiety proneness in pregnant women. These findings call for prospective studies to dissect the multifactorial influences on PPI in relation to mental health of pregnant women.
Assuntos
Transtornos de Ansiedade/genética , Transtornos de Ansiedade/metabolismo , Catecol O-Metiltransferase/genética , Catecol O-Metiltransferase/metabolismo , Hormônios/metabolismo , Filtro Sensorial/genética , Adulto , Transtornos de Ansiedade/tratamento farmacológico , Catecolaminas/genética , Estudos de Coortes , Feminino , Genótipo , Heterozigoto , Humanos , Gravidez , Inibição Pré-Pulso/genética , Estudos Prospectivos , Reflexo de Sobressalto/genética , Inibidores Seletivos de Recaptação de Serotonina/efeitos adversos , Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico , Fatores SocioeconômicosRESUMO
RATIONALE: Prepulse inhibition (PPI) of the acoustic startle response, a measure of sensorimotor gating, can be enhanced by nicotine. Moreover, the TT genotype of the nicotinic acetylcholine receptor (nAChR) α3-subunit (CHRNA3) rs1051730 polymorphism has previously been associated with diminished PPI and nicotine dependence. OBJECTIVES: We tested whether this CHRNA3 polymorphism also modulates the nicotine-induced enhancement of PPI. METHODS: We assessed the effect of nicotine on PPI, startle reactivity, and habituation in 52 healthy nonsmoking volunteers genotyped for CHRNA3 rs1051730 in a double-blind, placebo-controlled, counterbalanced, within-subjects design. Additionally, cotinine plasma levels were measured. RESULTS: Nicotine significantly enhanced PPI in TT homozygotes only and tended to worsen PPI in TC and CC carriers. Additionally, nicotine significantly reduced startle habituation. CONCLUSIONS: The present findings imply that the effect of nicotine on sensorimotor gating is modulated by nAChR α3-subunits. Thus, genetic variation in nicotinic receptor genes might be an important connecting link between early attentional processes and smoking behavior.
Assuntos
Nicotina/administração & dosagem , Polimorfismo Genético/genética , Receptores Nicotínicos/genética , Reflexo de Sobressalto/genética , Filtro Sensorial/genética , Estimulação Acústica/métodos , Administração Cutânea , Adulto , Método Duplo-Cego , Feminino , Variação Genética , Humanos , Masculino , Pessoa de Meia-Idade , Reflexo de Sobressalto/efeitos dos fármacos , Filtro Sensorial/efeitos dos fármacos , Adulto JovemRESUMO
Elevated smoking rates seen in schizophrenia populations may be an attempt to correct neuropathologies associated with deficient nicotinic acetylcholine receptors and/or dopaminergic systems using exogenous nicotine. However, nicotine's effects on cognitive processing and sensory gating have been shown to be baseline-dependent. Evidence of a restorative effect on sensory gating deficits by nicotine-like agonists has been demonstrated, however, its underlying mechanisms in the context of dopamine dysregulation are unclear. Catechol-O-methyltransferase (COMT), a key dopamine regulator in the brain, contains a co-dominant allele in which a valine-to-methionine substitution causes variations in enzymatic activity leading to reduced synaptic dopamine levels in the Val/Val genotype. Using a randomized, double-blind, placebo-controlled design with 57 non-smokers, this study examined the effects of COMT genotype on sensory gating and its modulation by nicotine in low vs. high suppressors. The results were consistent with the hypothesis that increased dopamine resulting from nicotine stimulation or Met allelic activity would benefit gating in low suppressors and impair gating in high suppressors, and that this gating improvement with nicotine would be more evident in Val carriers who were low suppressors, while the gating impairment would be more evident in Met carriers who were high suppressors. These findings reaffirm the importance of baseline-dependency and suggest a subtle relationship between COMT genotype and baseline-stratified levels of sensory gating, which may help to explain the variability of cognitive abilities in schizophrenia populations.
Assuntos
Catecol O-Metiltransferase/genética , Nicotina/farmacologia , Agonistas Nicotínicos/farmacologia , Filtro Sensorial/efeitos dos fármacos , Filtro Sensorial/genética , Adolescente , Adulto , Método Duplo-Cego , Potenciais Evocados/efeitos dos fármacos , Potenciais Evocados/genética , Genótipo , Humanos , Masculino , Reação em Cadeia da Polimerase em Tempo Real , Adulto JovemRESUMO
Following early clinical leads, the adenosine A(2A)R receptor (A(2A)R) has continued to attract attention as a potential novel target for treating schizophrenia, especially against the negative and cognitive symptoms of the disease because of A(2A)R's unique modulatory action over glutamatergic in addition to dopaminergic signaling. Through (i) the antagonistic interaction with the dopamine D(2) receptor, and (ii) the regulation of glutamate release and N-methyl-d-aspartate receptor function, striatal A(2A)R is ideally positioned to fine-tune the dopamine-glutamate balance, the disturbance of which is implicated in the pathophysiology of schizophrenia. However, the precise function of striatal A(2A)Rs in the regulation of schizophrenia-relevant behavior is poorly understood. Here, we tested the impact of conditional striatum-specific A(2A)R knockout (st-A(2A)R-KO) on latent inhibition (LI) and prepulse inhibition (PPI) - behavior that is tightly regulated by striatal dopamine and glutamate. These are two common cross-species translational tests for the assessment of selective attention and sensorimotor gating deficits reported in schizophrenia patients; and enhanced performance in these tests is associated with antipsychotic drug action. We found that neither LI nor PPI was significantly affected in st-A(2A)R-KO mice, although a deficit in active avoidance learning was identified in these animals. The latter phenotype, however, was not replicated in another form of aversive conditioning - namely, conditioned taste aversion. Hence, the present study shows that neither learned inattention (as measured by LI) nor sensory gating (as indexed by PPI) requires the integrity of striatal A(2A)Rs - a finding that may undermine the hypothesized importance of A(2A)R in the genesis and/or treatment of schizophrenia.
Assuntos
Aprendizagem da Esquiva/fisiologia , Corpo Estriado/metabolismo , Inibição Psicológica , Deficiências da Aprendizagem/genética , Receptor A2A de Adenosina/deficiência , Filtro Sensorial/genética , Análise de Variância , Animais , Condicionamento Psicológico/fisiologia , Proteínas de Homeodomínio/genética , Deficiências da Aprendizagem/fisiopatologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Atividade Motora/genética , Psicoacústica , Reflexo Acústico/genética , Paladar/genéticaRESUMO
The complex pathogenesis of anxiety and panic disorder in particular has been suggested to be influenced by genetic factors such as the adenosine A2A receptor gene (ADORA2A) 1976T>C polymorphism (rs5751876) as well as neuropsychological factors such as early information processing deficits. In 114 healthy individuals (males=57, females=57) controlled for anxiety sensitivity (AS), a multi-level risk model of the development of anxiety was applied: Genetic (ADORA2A 1976T>C variant) and biochemical (300 mg of caffeine citrate vs. placebo) factors were hypothesized to influence early information processing as measured by the prepulse inhibition/facilitation paradigm (stimulus onset asynchronies (SOAs) of 60, 120, 240, 480 and 2000ms between prepulses and startle stimuli). A fourfold interaction of genotype, intervention, gender, and SOAs was discerned. Stratification by SOAs revealed that at 120 ms and 240 ms SOAs in the caffeine condition, PPI was impaired in female ADORA2A 1976TT risk genotype carriers as compared to male ADORA2A 1976TT homozygotes, while no significant effects were observed in the ADORA2A 1976CC/CT non-risk genotype or placebo group. Only in high anxiety sensitive probands, a significant intervention effect was discerned with impaired prepulse facilitation (PPF) due to caffeine. The present results point to an impaired ability to selectively process very early information and to gate irrelevant sensory information, respectively, in female ADORA2A 1976TT homozygotes in response to caffeine, providing further evidence for the adenosinergic system to be involved in the pathogenesis of anxiety.
Assuntos
Ansiedade/genética , Cafeína/farmacologia , Variação Genética , Receptor A2A de Adenosina/genética , Filtro Sensorial/efeitos dos fármacos , Filtro Sensorial/genética , Adulto , Ansiedade/psicologia , Feminino , Genótipo , Humanos , Masculino , Reflexo de Sobressalto/efeitos dos fármacos , Reflexo de Sobressalto/genética , Fatores SexuaisRESUMO
Schizophrenia is a debilitating psychotic disorder that affects up to 1.5% of the population worldwide. Two recent studies in humans identified genome-wide significant associations between schizophrenia and single-nucleotide polymorphisms (SNPs) in an intron of CSMD1. The effect of deleting CSMD1 on mouse behavior is unknown. The present study utilized mice with a mutant Csmd1 allele in which the first exon had been ablated (KO mice). All Csmd1 transcripts that included the first exon were absent in the brains of KO mice, but there was persistent expression of at least one other transcript that does not include the first exon. Wild type (WT), heterozygous (HET), and KO mice were assessed using several well-established behavioral paradigms that model aspects of schizophrenia. Csmd1 KO mice did not differ from wild-type littermates for sensorimotor gating (measured as prepulse inhibition), social interaction, anhedonia (measured by sucrose preference), or sensitivity to the locomotor stimulant effects of the dopaminergic agent d-amphetamine. These data demonstrate that loss of Csmd1 transcripts that include the first exon does not alter multiple well-established behaviors that model aspects of schizophrenia. The SNP most strongly associated with schizophrenia in humans is between exons 3 and 4; therefore, ablation of exon 1 appeared to be a logical animal model. Nevertheless, future studies should consider alternative mouse models including gain-of-function mutations, and loss-of-function mutations that target alternative transcripts of Csmd1.
Assuntos
Comportamento Animal , Proteínas de Membrana/genética , Mutação , Esquizofrenia/genética , Proteínas Supressoras de Tumor/genética , Alelos , Animais , Comportamento Animal/efeitos dos fármacos , Dextroanfetamina/farmacologia , Modelos Animais de Doenças , Éxons/genética , Feminino , Preferências Alimentares/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/genética , Técnicas de Inativação de Genes , Masculino , Proteínas de Membrana/deficiência , Camundongos , Esquizofrenia/fisiopatologia , Filtro Sensorial/efeitos dos fármacos , Filtro Sensorial/genética , Comportamento Social , Sacarose , Proteínas Supressoras de Tumor/deficiênciaRESUMO
Brain-derived neurotrophic factor (BDNF) signalling through its receptor, TrkB is known to regulate GABAergic function and glutamic acid decarboxylase (GAD) 67 expression in neurons. Alterations in BDNF signalling have been implicated in the pathophysiology of schizophrenia and as a result, they are a potential therapeutic target. Interestingly, heterozygous reeler mice (HRM) have decreased GAD67 expression in the frontal cortex and hippocampus and they exhibit many behavioural and neurochemical abnormalities similar to schizophrenia. In this study, we evaluated the potential of cysteamine, a neuroprotective compound to improve the deficits in GAD67 expression and cognitive function in HRM. We found that cysteamine administration (150 mg/kg.d, through drinking water) for 30 d significantly ameliorated the decreases in GAD67, mature BDNF and full-length TrkB protein levels found in frontal cortex and hippocampus of HRM. A significant attenuation of the increased levels of truncated BDNF in frontal cortex and hippocampus, as well as truncated TrkB in frontal cortex of HRM was also observed following cysteamine treatment. In behavioural studies, HRM were impaired in a Y-maze spatial recognition memory task, but not in a spontaneous alternation task or a sensorimotor, prepulse inhibition (PPI) procedure. Cysteamine improved Y-maze spatial recognition in HRM to the level of wide-type controls and it improved PPI in both wild-type and HRM. Finally, mice deficient in TrkB, showed a reduced response to cysteamine in GAD67 expression suggesting that TrkB signalling plays an important role in GAD67 regulation by cysteamine.
Assuntos
Cisteamina/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Glutamato Descarboxilase/metabolismo , Memória/efeitos dos fármacos , Percepção Espacial/efeitos dos fármacos , Estimulação Acústica/efeitos adversos , Análise de Variância , Animais , Lobo Frontal/efeitos dos fármacos , Lobo Frontal/metabolismo , Regulação da Expressão Gênica/genética , Glutamato Descarboxilase/genética , Heterozigoto , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Camundongos , Camundongos Knockout , Camundongos Mutantes Neurológicos , Receptor trkB/deficiência , Receptor trkB/metabolismo , Filtro Sensorial/efeitos dos fármacos , Filtro Sensorial/genética , Fatores de TempoRESUMO
Although schizophrenia has been considered primarily a disease of dopaminergic neurotransmission, the role of dopamine in auditory sensory gating deficits in this disorder and their amelioration by smoking/nicotine is unclear. Hypothesizing that individual differences in striatal dopamine levels may moderate auditory gating and its modulation by nicotine, this preliminary study used the mid-latency (P50) auditory event-related potential (ERP) to examine the single dose (6 mg) effects of nicotine (vs. placebo) gum on sensory gating in 24 healthy nonsmokers varying in the genetic expression of the dopamine transporter (DAT). Consistent with an inverted-U relationship between dopamine level and the drug effects, individuals carrying the 9R (lower gene expression) allele, which is related to greater striatal dopamine levels, tended to evidence increased baseline gating compared to 10R (higher gene expression) allele carriers and showed a reduction in gating with acute nicotine. The present results may help to understand the link between excessive smoking and sensory gating deficits in schizophrenia and to explain the potential functional implications of genetic disposition on nicotinic treatment in schizophrenia.
Assuntos
Proteínas da Membrana Plasmática de Transporte de Dopamina/genética , Nicotina/farmacologia , Agonistas Nicotínicos/farmacologia , Filtro Sensorial/efeitos dos fármacos , Filtro Sensorial/genética , Adolescente , Adulto , Encéfalo/efeitos dos fármacos , Encéfalo/fisiologia , Estudos Cross-Over , Dopamina/metabolismo , Método Duplo-Cego , Potenciais Evocados Auditivos/efeitos dos fármacos , Potenciais Evocados Auditivos/fisiologia , Feminino , Genótipo , Humanos , Masculino , Reação em Cadeia da Polimerase , Esquizofrenia/genética , Esquizofrenia/fisiopatologia , Adulto JovemRESUMO
Mice lacking the neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) (PACAP(-/-)) display behavioral abnormalities, and genetic variants of the genes encoding PACAP are associated with schizophrenia. Clinical studies show that environmental factors, besides genetic factors, play a key role in etiology of many psychiatric disorders. This study examined the effects of environmental factors such as short-term social isolation and an enriched environment on behavioral abnormalities of PACAP(-/-) mice. Rearing in isolation for 2-weeks from 4-weeks old induced hyperlocomotion and aggressive behaviors in the PACAP(-/-) mice without affecting the behavioral performance of the wild-type controls. Adult PACAP(-/-) mice showed not only hyperactivity, jumping behavior, and depression-like behavior, but also decreased social interaction. These abnormal behaviors were improved by rearing for 4-weeks in an early enriched environment (from 4-weeks old), although the deficits of prepulse inhibition (PPI) were not influenced by the enriched condition. In contrast, rearing for 4-weeks in late enriched environment (from 8-weeks old) did not affect the hyperactivity and jumping behaviors in the PACAP(-/-) mice. These results suggest that abnormal behaviors except PPI deficits in PACAP(-/-) mice depend on the environmental factors during the early stages of development.
Assuntos
Ansiedade/genética , Polipeptídeo Hipofisário Ativador de Adenilato Ciclase/genética , Comportamento Social , Meio Social , Isolamento Social , Fatores Etários , Agressão/fisiologia , Análise de Variância , Animais , Comportamento Animal/fisiologia , Comportamento Exploratório/fisiologia , Camundongos , Camundongos Knockout , Atividade Motora/genética , Filtro Sensorial/genética , NataçãoRESUMO
Evidence of normalized auditory P50 suppression with acute nicotine in schizophrenia has supported the contention that elevated smoking rates in this disorder may be an attempt to correct a nicotinic receptor pathophysiology that may underly impaired sensory gating in these patients. There is very little information regarding the neurochemical or genetic pathways through which nicotine regulates P50 amplitude and its suppression in human studies. In a randomized, double-blind, placebo-controlled design with 24 non-smokers, this study examined the influence of TaqIA dopamine D2 receptor gene polymorphisms on P50 and its inhibition during nicotine gum (6 mg) administration. Within a paired click (S(1)-S(2)) paradigm, placebo treated A1(+) and A1(-) allele groups differed with respect to P50 amplitude and gating. While nicotine (relative to placebo) attenuated S(1) P50 amplitude in A1(+) allele carriers, in the A1(-) carriers it increased S(2) P50 amplitude and increased P50 gating as indexed by an augmented gating difference wave (GDW). These findings suggest that nicotine exerts mixed gating properties in healthy nicotine naive volunteers and that dopamine functions to alter both P50 and its gating as well as their response to acute nicotine agonist treatment.
Assuntos
Córtex Cerebral/efeitos dos fármacos , Dopamina/metabolismo , Potenciais Evocados Auditivos/efeitos dos fármacos , Nicotina/farmacologia , Receptores de Dopamina D2/efeitos dos fármacos , Filtro Sensorial/efeitos dos fármacos , Estimulação Acústica , Adolescente , Adulto , Córtex Cerebral/metabolismo , Análise Mutacional de DNA , Método Duplo-Cego , Eletroencefalografia/efeitos dos fármacos , Potenciais Evocados Auditivos/genética , Feminino , Frequência do Gene/genética , Testes Genéticos , Genótipo , Humanos , Masculino , Testes Neuropsicológicos , Agonistas Nicotínicos/farmacologia , Placebos , Polimorfismo Genético/efeitos dos fármacos , Polimorfismo Genético/genética , Receptores de Dopamina D2/genética , Filtro Sensorial/genética , Tabagismo/genética , Tabagismo/metabolismo , Tabagismo/fisiopatologia , Adulto JovemRESUMO
Schizophrenia, if not the most difficult, is one of the most difficult mysterious puzzles for psychiatrists, psychologists, and neuroscientists to solve. In this paper, based on the previously known pathologies of schizophrenia, a new model is proposed for explanation of the formation of positive psychotic symptoms of hallucinations and delusions. This model can be used for understanding psychotic or psychotic-like positive symptoms of bipolar mood disorder, posttraumatic stress disorder, obsessive compulsive, and amphetamine and drug-induced psychotic disorders. Based on the postulated model, a spectral view on these disorders with psychotic features is also proposed. These pathologies include auditory sensory gating deficits in hippocampus, abnormal emotional coding in amygdala, pattern completion in thalamic and cortical areas, and disturbed fronto-limbic balance. This model includes anatomical and neurotransmitter defects of hippocampus, amygdala, thalamus, cingula, and prefrontal cortex and their interconnections. A role for hippocampal sensory gating deficits in the pathogenesis of positive psychotic symptoms and interrelation between amygdala and its dopamine level with hippocampus is speculated. This model also hires the interesting function of pattern completion in thalamus and cortical areas for a better explanation of the pathogenesis of hallucinations and delusional psychotic symptoms. Furthermore, there is also explanation for the polygenic etiology of the schizophrenic and psychotic disorders and relation between schizophrenia and bipolar mood disorder in anatomy and neural systems involved. A spectral view is proposed that explains the absence of clear cut border between different psychotic or psychotic-like disorders in their form and severity based on the involved genes and brain functional systems. Including excessive prefrontal pruning, there is also explanation for the appearance of positive psychotic symptoms in early adulthood. An explanation for the high dopamine level of amygdala despite its decreased size and abnormal anatomy is also suggested as a compensatory function which might explain the decline in positive psychotic symptoms when schizophrenics age according to amygdala burn out. Based on this model, speculations are provided for: late onset of the effects of antipsychotics on positive psychotic symptoms, mechanism for the therapeutic effect of serotonin type 2A receptor blockers and GABAergic medications in psychosis, role of smoking in diminution of psychotic symptoms, and relationship between biological and psychological issues in the formation of psychotic symptoms. Finally, based on this model, a new role for nicotinic cholinergic drugs (such as galantamine) for treatment of schizophrenia and other psychotic or psychotic-like disorders is proposed.